Inactive Instrument

Company New York Global Innovations Inc Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

2023	Manuka, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Manuka, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Artemis Therapeutics, Inc. is a shell company. The Company has not commenced any operating business. The Company has not generated revenues.

Managers	Title	Age	Since
Shimon Citron CEO	Chief Executive Officer	70	30/22/30
David Dana DFI	Director of Finance/CFO	60	26/22/26
Dana Wolf CTO	Chief Tech/Sci/R&D Officer	66	02/16/02
Haim Tabak COO	Chief Operating Officer	76	01/20/01

Members of the board	Title	Age	Since
Shimon Citron CEO	Chief Executive Officer	70	30/22/30

Name	Equities	%	Valuation
Shimon Citron 72.06 %	80,729,883	72.06 %	3 M $
Chomsky Adler Marketing Communication Ltd. 11.26 %	12,614,868	11.26 %	504 595 $
Eyal Chomsky Holdings Ltd. 3.753 %	4,204,382	3.753 %	168 175 $

Manuka, Inc.

18 East 16th Street Suite 307

10003, New York

This company's sector is not yet available